HB Surface Antigen Level as a Useful Predictor for the Treatment Response to Tenofovir Alafenamide in Nucleoside Analogue Naïve Chronic Hepatitis BArticle Published on 2023-03-012023-06-12 Journal: In vivo (Athens, Greece) [Category] B형 간염, [키워드] Chronic Hepatitis B HBsAg Predictor. Tenofovir alafenamide [DOI] 10.21873/invivo.13134 PMC 바로가기
Retreatment Efficacy and Renal Safety of Tenofovir Alafenamide, Entecavir, and Tenofovir Disoproxil Fumarate After Entecavir or Tenofovir CessationArticle Published on 2023-02-012023-06-13 Journal: Digestive diseases and sciences [Category] B형 간염, [키워드] entecavir hepatitis B surface antigen Hepatitis B virus Tenofovir alafenamide tenofovir disoproxil fumarate. [DOI] 10.1007/s10620-022-07657-8 PMC 바로가기
Tenofovir Alafenamide for Pregnant Chinese Women With Active Chronic Hepatitis B: A Multicenter Prospective StudyMulticenter Study Published on 2022-12-012023-06-12 Journal: Clinical gastroenterology and hepatology : the off [Category] B형 간염, [키워드] Chronic Hepatitis B Effectiveness Mother-to-child transmission Pregnancy Safety Tenofovir alafenamide tenofovir disoproxil fumarate. [DOI] 10.1016/j.cgh.2021.12.012 PMC 바로가기 [Article Type] Multicenter Study
Comparison of the side effects of antivirals in chronic hepatitis B patients: a single-center experienceArticle Published on 2022-10-012023-06-13 Journal: Acta gastro-enterologica Belgica [Category] B형 간염, [키워드] Chronic Hepatitis B entecavir Tenofovir alafenamide tenofovir disoproxil fumarate. [DOI] 10.51821/85.4.10634 PMC 바로가기
Tenofovir alafenamide is associated with improved alanine aminotransferase and renal safety compared to tenofovir disoproxil fumarateArticle Published on 2022-09-012023-06-12 Journal: Journal of medical virology [Category] B형 간염, [키워드] alanine aminotransferase chronic Chronic kidney disease hepatitis B Tenofovir alafenamide tenofovir disoproxil fumarate. [DOI] 10.1002/jmv.27863 PMC 바로가기
Switching to tenofovir alafenamide for nucleos(t)ide analogue-experienced patients with chronic hepatitis B: week 144 results from a real-world, multi-centre cohort studyMulticenter Study Published on 2022-08-012023-06-13 Journal: Alimentary pharmacology & therapeutics [Category] B형 간염, Fulltext, [키워드] Chronic kidney disease entecavir Hepatitis B virus Tenofovir alafenamide tenofovir disoproxil fumarate. [DOI] 10.1111/apt.17107 PMC 바로가기 [Article Type] Multicenter Study
Impact of tenofovir on SARS-CoV-2 infection and severe outcomes among people living with HIV: a propensity score-matched studySARS-CoV-2 감염 및 HIV 감염자의 심각한 결과에 대한 테노포비르의 영향: 성향 점수 일치 연구Article Published on 2022-07-282022-09-11 Journal: Journal of Antimicrobial Chemotherapy [Category] COVID19(2023년), SARS, 치료제, [키워드] 95% CI 95% confidence interval adjusted adjusted odds ratio Analysis antiretroviral association baseline characteristics Clinical outcome Cohort conducted Cox regression model Diagnosis disease severity emtricitabine evaluated Hospitalization Impact intrinsically logistic regression models management modify Odds ratio outcome outcomes PLWH Propensity score recipient recipients reduced report SARS-CoV-2 SARS-COV-2 infection Spain TDF/FTC tenofovir Tenofovir alafenamide tenofovir disoproxil tenofovir disoproxil fumarate therapeutic with HIV [DOI] 10.1093/jac/dkac177 PMC 바로가기 [Article Type] Article
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis BArticle Published on 2022-07-012023-06-13 Journal: Liver international : official journal of the Inte [Category] B형 간염, [키워드] Chronic Hepatitis B Hepatocellular carcinoma Tenofovir alafenamide tenofovir disoproxil fumarate. [DOI] 10.1111/liv.15261 PMC 바로가기
Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆Article Published on 2022-07-012023-06-11 Journal: Journal of the Formosan Medical Association = Taiw [Category] B형 간염, [키워드] body weight Effectiveness HBV Tenofovir alafenamide Tolerability. [DOI] 10.1016/j.jfma.2021.09.009 PMC 바로가기
The Nucleoside/Nucleotide Analogs Tenofovir and Emtricitabine Are Inactive against SARS-CoV-2뉴클레오사이드/뉴클레오타이드 유사체 테노포비르와 엠트리시타빈은 SARS-CoV-2에 대해 비활성입니다Article Published on 2022-06-302022-09-11 Journal: Molecules [Category] COVID19(2023년), SARS, 치료제, [키워드] accelerated active site acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antiviral activity antiviral agent Antiviral agents Antiviral effect approaches approved approved drug biochemical causative pathogen caution Cell clinicians and researcher Concentration coronavirus COVID-19 COVID-19 pandemic demonstrated Efficiency emtricitabine epithelial FTC HIV-1 HIV-1 NRTI human lung in vitro data inactive indicate inhibitor lack metabolite NHBE NTP nucleoside polymerase Prevent RdRP RdRp active site required reverse transcriptase RNA polymerase SARS-CoV-2 SARS-CoV-2 RNA severe acute respiratory syndrome Coronavirus TAF TDF tenofovir Tenofovir alafenamide tenofovir. the SARS-CoV-2 transcriptase treat unlikely [DOI] 10.3390/molecules27134212 PMC 바로가기 [Article Type] Article